| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,982 | 11,475 | 11,154 | 11,783 | | Cost of Revenue | 2,791 | 3,196 | 3,528 | 3,836 | | | Gross Profit |
-
| 8,279 | 7,626 | 7,948 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,362 | 5,192 | 4,608 | 4,321 | | Non Recurring | (214) | (34) | 248 | 64 | | Others | 4,056 | 1,811 | 1,201 | 1,753 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,310 | 1,569 | 1,809 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (13) | 1,310 | 1,569 | 1,809 | | Interest Expense | 1,156 | 1,150 | 1,174 | 1,390 | | Income Before Tax | (1,169) | 160 | 395 | 419 | | Income Tax Expense | (671) | (155) | (61) | (8) | | Minority Interest | 513 | (513) |
-
|
-
| | | | Net Income From Continuing Ops | 15 | (198) | 456 | 427 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15 | (198) | 456 | 427 | | Preferred Stock And Other Adjustments | (774) | 253 | (253) |
-
| | | Net Income Applicable To Common Shares | ($759) | $55 | $203 | $427 |
|
0.31% Nasdaq 
0.05%
Income Statement
